Archives: October 21 – 31, 2010

2010 Recent Advances in Internal Medicine — BLOG AVAILABLE ON NOVEMBER 1

Join physician-blogger Dr. Cynthia Christiano as she blogs about the nephrology-specific talks at the 2010 East Carolina University Recent Advances in Internal Medicine Conference.

Her blog is available by clicking here.

*** Note: Only registered users can participate in the virtual discussion. Not a registered user but interested in becoming one? Click here to complete our quick registration form.


The Division of Nephrology and Hypertension at East Carolina University is now enrolling patients for the SPRINT Trial. The Systolic Blood PRessure INtervention Trial is an NIH-sponsored investigation to assess cardiovascular outcomes and all-cause mortality in patients randomized to intensive sBP control (< 120 mmHg) or standard sBP control (< 140 mmHg) over a 6-year followup period.

ECU is recruiting patients for this trial. To enroll your patient in the trial, please click here and complete a short questionnaire. A member of our research team will contact you with additional information.


This interactive crossword puzzle requires JavaScript and a reasonably recent web browser, such as Internet Explorer 5.5 or later, Netscape 7, Mozilla, Firefox, or Safari. If you have disabled web page scripting, please re-enable it and refresh the page. If this web page is saved to your computer, you may need to click the yellow Information Bar at the top of the page to allow the puzzle to load.



  • 1. 30% of all primary aldosterone cases have this
  • 2. All confirmatory testing for the diagnosis of primary aldosteronism can be done safely only if this is repleted first
  • 3. This drug class theoretically decreases levels of plasma renin activity (___-___)
  • 4. The most common cause of secondary hypertension
  • 5. Angiotensin-converting enzymes and angiotensin receptor blockers must be discontinued before administering the ARR screening test
  • 6. The aldosterone:renin ratio is a type of ___ test
  • 7. This phenomenom prevents edema from developing in patients with primary aldosteronism (___-___)
  • 8. The absence of hypokalemia is a reliable indicator of not having primary aldosteronism
  • 9. The type of hypertension that leads most physicians to perform screening tests for primary aldosteronism


  • 10. This clinical entity presents very similarly to primary aldosteronism and can be ruled out by checking for urinary 18-hydroxycortisol (________-________-__________)
  • 11. This drug class theoretically increases plasma renin activity
  • 12. The next necessary step after an adrenal CT scan (____-___-_____)
  • 13. Only mineralocorticoid-receptor antagonists and potassium-sparing diuretics must be discontinued prior to administering the aldosterone:renin screening test
  • 14. Stroke, heart attacks, atrial fibrillation, and this are all increased in primary aldosterone patients than in any other etiology of hypertension
  • 15. The time of day when the aldosterone:renin ratio should be performed for most accurate measurements
  • 16. This group is more likely to suffer from hypokalemic periodic paralysis
  • 17. PHysician who first mentioned a hypertensive patient with hypokalemia (mentioned in his 1954 presidential address at the Central Society for Clinical Research)

Top Times

  • No Times Recorded Yet

Abstract Submissions — UPDATED NOVEMBER 1, 2010

Keep your eyes on Nephrology On-Demand for more information on the following meetings:

International Forum on Quality and Safety in Healthcare 2011 — Abstract Deadline September 24, 2010
NKF Spring Clinical Meeting 2011 — Abstract Deadline December 3, 2010
North American Society for Dialysis and Transplantation 2010 — Abstract Deadline May 28, 2010
Southern Society for Clinical Investigation 2011 – Young Investigators Forum (YIF) — Abstract deadline October 18, 2010
ACP Medical Student Abstract Competition 2011 — deadline expected to be early-December 2010
ACP Resident and Fellows Abstract Competition 2011 — expected deadline not yet announced; check back in August October 2010 for more information
ISN Abstract Competition 2011 — expected deadline not yet announced
American Transplant Congress 2011 — Abstract Deadline December 3, 2010
International Society of Blood Purification — Abstract Deadline July August 30, 2010
Evidence 2010 — Abstract Deadline August 6, 2010
American Federation of Medical Research: Southern Regional Meetings 2011 — Abstract Deadline October 15, 2010
American Federation of Medical Research: Western Regional Meetings 2011 — Abstract Deadline October 1, 2010
American Society of Hypertension 2011 — Abstract Deadline December 6, 2010
International CRRT Meeting 2011 — Abstract Deadline December 3, 2010

  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription